PT  - JOURNAL ARTICLE
AU  - WOJCIECH FORTUNA
AU  - BENITA WIATRAK
AU  - PAULINA JAWIEŃ
AU  - ADRIANA KUBIS-KUBIAK
AU  - YING LI
AU  - DAQING LI
AU  - PAWEŁ TABAKOW
TI  - Three-dimensional Collagen Scaffolds in Cultures of Olfactory Ensheathing Cells Used for Severed Spinal Cord Regeneration
AID  - 10.21873/invivo.12929
DP  - 2022 Sep 01
TA  - In Vivo
PG  - 2032--2041
VI  - 36
IP  - 5
4099  - http://iv.iiarjournals.org/content/36/5/2032.short
4100  - http://iv.iiarjournals.org/content/36/5/2032.full
SO  - In Vivo2022 Sep 01; 36
AB  - Background/Aim: The regeneration of a completely damaged spinal cord is still a challenge in modern medicine. A promising treatment method is autologous transplantation of olfactory ensheathing cells (OECs). This study aimed primarily to test methods of culturing OECs with the use of materials and reagents that are certified for pharmaceutical use in the production of an advanced cell therapy product intended for humans. Materials and Methods: The culture of OECs was performed using various modifications of the surface of the culture vessels (with fibronectin and poly-D-lysine). The number of cells was assessed after immunofluorescence staining using anti-fibronectin and anti-p75 NGF receptor antibodies. The study compared, in terms of surgical manipulations, scaffolds with OECs prepared based on 3 types of collagen: Acid Solubilized Telo Collagen and Pepsin Solubilized Atelocollagen, and the popular Corning collagen. Results: We have shown that when suspending OECs in collagen gel, it is much better to use acid-solubilized collagen (ASC) than pepsin-solubilized collagen (PSC) because the 3D collagen scaffold from ASC provides much easier handling of the product during a surgical procedure. We also found that the OEC cultures should be grown on the surface modified with fibronectin. Furthermore, we have also shown that the optimal concentration of fetal bovine serum (FBS) for culturing these cells should be around 10%. Conclusion: The culture of OECs based on reagents intended for human use can be successfully carried out, obtaining sufficient OECs content in the heterogeneous cell culture to produce a functional advanced therapy medicinal product.